These pages provide visibility to Repligen news, SEC filings, financial and other information that may factor into an investment decision. We welcome your questions or comments.   

investors@repligen.com

Press Releases

Search Press Releases
  
Subscribe for Email Alerts
11/9/2017
7:30 AM ET
Earnings Release

Repligen Reports Third Quarter 2017 Financial Results

11/9/2017

Record quarterly revenue of $36.6 million represents 48% year-over-year growthYear-to-date revenue of $99.6 million represents 26% year-over-year growthSpectrum contributes revenue of $7.6 million in...

 Continue Reading
11/7/2017
7:30 AM ET
Press Release

Repligen Extends Long Term Supply Agreement with Purolite for Protein A Ligands

11/7/2017

Waltham, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that is has extended a long-term supply agreement with Purolite Life Sciences for the manufacture...

 Continue Reading
11/1/2017
11:14 AM ET
Press Release

Repligen to Report Third Quarter 2017 Financial Results

11/1/2017

WALTHAM, Mass., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report third quarter of 2017 financial results on Thursday, November 9, 201...

 Continue Reading
9/15/2017
7:30 AM ET
Press Release

Repligen Announces Analyst Day and Webcast

9/15/2017

WALTHAM, Mass., Sept. 15, 2017 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will host an institutional investor and analyst meeting on Friday, September 29...

 Continue Reading
8/30/2017
3:20 PM ET
Press Release

Repligen to Present at Baird’s 2017 Global Healthcare Conference

8/30/2017

WALTHAM, Mass., Aug. 30, 2017 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that management will pre...

 Continue Reading
Displaying 1 to 5 (of 205 releases)